Innovative drug concept plate active in the early stage, Shu Taishen rises more than 15%.

In early trading, Shu Tai Shen surged more than 15%, Hehua shares hit the limit up, Haichuang Pharmaceutical, Chengda Pharmaceutical, Zejing Pharmaceutical, Rongchang Biology, Rejing Biology, Bei Jing Shenzhou, and others followed suit.